mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.6 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.6 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |